samedan logo
 
 
 
spacer
home > ebr > spring 2008 > modular solutions for low resolution
PUBLICATIONS
European Biopharmaceutical Review

Modular Solutions for Low Resolution

Nick Barnett of Ocean Optics discusses how modular Raman spectroscopy can be used in the measurement of pharmaceutical active ingredients and excipients

Raman spectroscopy is an extremely useful technique for chemical analysis. Raman measurements are non-destructive, require very limited sample preparation and allow for sample volumes in the microlitre range. Raman techniques can even be used to acquire data through vial walls, pill pack windows and bags packaging forms that are frequently used in the biomedical and pharmaceutical industries.

In recent years, low resolution Raman spectroscopy (LRRS) has gained increased attention and acceptance in the analytical laboratory as an affordable, robust and convenient alternative to cumbersome wet chemical analysis or expensive FT-Raman and FT-IR spectrometers. Unlike high-resolution Raman spectrometers that are often capable of resolving peaks of less than three or four wave numbers apart, the new miniaturised systems relinquish resolution in favour of emphasising basic identifying spectral features, or fingerprints, that are often distinct and clearly separated. Recent advances allow some of the high-end LRRS systems to compete around the four cm-1 resolution.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Nick Barnett is the Country Manager for the UK and Ireland at Ocean Optics. He has an MSc in Optoelectronics and Laser Devices and a PhD in Biomedical Optics. Nick has previously worked in various R&D roles working on optical sensors, laser Doppler and NIR spectroscopy. He has been working for Ocean Optics for five years where his responsibilities include full business development, sales and technical support.
spacer
Nick Barnett
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Hope for a new treatment for the autoimmune neuromuscular disease Myasthenia Gravis (MG)

- The biotech companies 3P Biopharmaceuticals and Toleranzia collaborate for that MG treatment - MG is an orphan disease which has a major unmet medical need and a large market potential - The drug candidate,TOL2, has already achieved several positive preclinical results
More info >>

White Papers

Accelerating the Time from DNA to Material

Merck

Cell line development is a critical step in upstream process development for monoclonal antibodies (mAbs). Unfortunately, the search for the bestproducing clone can be labor- and resource-intensive and is often compared with looking for a needle in a haystack. Cells must first be engineered to produce the biologic of interest and the cell line generated from a high producing clone must deliver a sufficiently high titer to support clinical studies, and ultimately commercialization of the therapeutic.
More info >>

 
Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement